<SEC-DOCUMENT>0002034802-24-000002.txt : 20241226
<SEC-HEADER>0002034802-24-000002.hdr.sgml : 20241226
<ACCEPTANCE-DATETIME>20241226154004
ACCESSION NUMBER:		0002034802-24-000002
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20241226
DATE AS OF CHANGE:		20241226

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sonoma Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001367083
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				680423298
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-33216
		FILM NUMBER:		241580859

	BUSINESS ADDRESS:	
		STREET 1:		5445 CONESTOGA COURT, SUITE 150
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		800-759-9305

	MAIL ADDRESS:	
		STREET 1:		5445 CONESTOGA COURT, SUITE 150
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oculus Innovative Sciences, Inc.
		DATE OF NAME CHANGE:	20060622

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gottfurcht Grant
		CENTRAL INDEX KEY:			0002034802
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		1018 HARTZELL ST
		CITY:			PACIFIC PALISADES
		STATE:			CA
		ZIP:			90272
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002034802</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001367083</issuerCik>
      <issuerName>Sonoma Pharmaceuticals, Inc.</issuerName>
      <secFileNumber>001-33216</secFileNumber>
      <issuerAddress>
        <com:street1>5445 CONESTOGA COURT, SUITE 150</com:street1>
        <com:city>BOULDER</com:city>
        <com:stateOrCountry>CO</com:stateOrCountry>
        <com:zipCode>80301</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>800-759-9305</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Gottfurcht Grant</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Merrill Lynch</name>
        <address>
          <com:street1>9560 Wilshire Blvd. 3rd Floor</com:street1>
          <com:city>Beverly Hills</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>90212</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>221375</noOfUnitsSold>
      <aggregateMarketValue>56457.00</aggregateMarketValue>
      <noOfUnitsOutstanding>2988625</noOfUnitsOutstanding>
      <approxSaleDate>08/09/2024</approxSaleDate>
      <securitiesExchangeName>NASQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Stock</securitiesClassTitle>
      <acquiredDate>07/05/2024</acquiredDate>
      <natureOfAcquisitionTransaction>Open Market</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Grant Gottfurcht</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>289842</amountOfSecuritiesAcquired>
      <paymentDate>07/05/2024</paymentDate>
      <natureOfPayment>Open Market Purchase</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>I purchased these stocks because I like the company.  I have no affiliation with the company.</remarks>
    <noticeSignature>
      <noticeDate>12/26/2024</noticeDate>
      <signature>Grant Gottfurcht</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
